Inhibition of Poly(ADP-ribose) polymerase: Reduction of ischemic injury and attenuation of N-methyl-D-aspartate-induced neurotransmitter dysregulation

Stroke

Volumn 29, Issue 4, 1998, Pages 830-836

  Lo, Eng H ^a,b   Bosque Hamilton, Prince ^a   Meng, Wei ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

DNA repair; Excitotoxicity; Glutamates; Nitric oxide; Rats; Stroke, ischemic

Indexed keywords

ETHANOLAMINE DERIVATIVE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ARTERY; DNA REPAIR; HEART MUSCLE ISCHEMIA; MIDDLE CEREBRAL ARTERY; NEUROMODULATION; NEUROPROTECTION; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION; STROKE;

EID: 0031946532     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.4.830     Document Type: Article

References (51)

1. Choi DW. Excitotoxic cell death. J Neurobiol. 1992;23:1261-1276.
2. Rothman SM, Olney JW. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol. 1985;19:105-111.
3. Siesjo B, Bengtsson F. Ca fluxes, Ca antagonists and Ca-related pathology in brain ischemia hypoglycemia and spreading depression: a unifying hypothesis. J Cereb Blood Flow Melab. 1989;9:127-137.
4. Dawson DA. Nitric oxide and focal cerebral ischemia: multiplicity of actions and diverse outcomes. Cerehrovusc Brain Metab Rev. 1994;6: 299-324.
5. Iadecola C, Pelligrino DA, Moskowitz MA, Lassen NA. Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab. 1994;14:175-192.
6. Beckman JS. Peroxynitrite vs hydroxyl radical: the role of NO in superoxide-mediated cerebral injury. Ann N Y Acad Sci. 1994;738:69-75.
7. Chan PH. Role of oxidants in ischemic brain damage. Stroke. 1996;27: 1124-1130.
8. Zhang J, Dawson VL, Dawson TM, Snyder SH. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science. 1994;263: 687-689.
9. Zhang J, Pieper A, Snyder SH. Poly(ADP-ribose) synthetase activation: an earh indicator of neurotoxic DNA damage. J Neurochem. 1995;65: 1411-1414.
10. Lo EH, Pierce AR, Matsumoto K, Kano T, Evans CJ, Newcomb R. Alterations in K+ evoked profiles of neurotransmitter and neuromodulator amino acids after focal ischemia-reperfusion. Neuroscience. 1998;83:449-458.
11. Matsumoto K, Lo EH, Pierce AR, Halpern EF, Newcomb R. Secondary elevations in extracellular neurotransmitter amino acids in reperfusion phase following focal cerebral ischemia. J Cereb Blood Flow Metab. 1996;16:114-124.
12. Memezawa H, Minamisawa H, Smith ML, Siesjö BK. Ischemic penumbra in a model of reversible middle cerebral artery occlusion in the rat. Exp Brain Res. 1992;89:67-78.
13. Zea Longa E, Weinstein PR, Carlson S, Cummins R. Reversible middle artery occlusion without craniectomy. Stroke. 1989;20:84-91.
14. Lin TN, Yong YH, Wa G, Khan M, Hsu CY. Effect of brain edema on infarct volume in a focal ischemia model in rats. Stroke. 1992;23: 117-121.
15. Lo EH, Pierce AR, Mandeville JB, Rosen BR. Neuroprotection with NBQX in rat focal cerebral ischemia: effects on ADC probability distribution functions and diffusion-perfusion correlations. Stroke. 1997;28: 439-447.
16. Knowles RG, Palacios M, Palmer RJ, Moncada S. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc Natl Acad Sci USA. 1989;86:5159-5162.
17. Kaiser MG, During MJ. Combining laser Doppler flowmetry with microdialysis: a novel approach to investigate the coupling of regional cerebral blood flow to neuronal activity. J Neurosci Methods. 1995;60:165-173.
18. de Murcia G, Mennesier-de Murcia G, Schreiber V. Poly(ADP-ribose) polymerase: a molecular nick sensor. Trends Biochem Sci. 1994;19: 172-176.
19. Althaus FR, Richter C. ADP-ribosylation of proteins: enzymology and biological significance. Mol Biol Biochem Biophys. 1987;37:1-125.
20. Lindahl T, Satoh MS, Poirier GG, Klungland A. Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends Biochem Sci. 1995;20:405-411.
21. Schreiber V, Hunting D, Trucco C, Gowans B, Grunwald D, de Murcia G, de Murcia JM. A dominant-negative mutant of human poly(ADP-ribose) polymerase affects cell recovery, apoptosis, and sister chromatid exchange following DNA damage. Proc Natl Acad Sci USA. 1995;92: 4753-4757.
22. Kondo T, Reaume AG, Huang T, Carlson E, Murakami K, Chen SF, Hoffman RW, Scott RW, Epstein CJ, Chan PH. Reduction of CuZn superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J Neurosci. 1997;17: 4180-4189.
23. Liu PK, Hsu CY, Dizdaroglu M, Floyd RA, Kow YW, Karakaya A, Rabow LE, Cui J. Damage, repair and mutagenesis in nuclear genes after mouse forebrain ischemia-reperfusion. J Neurosci. 1996;16:6795-6806.
24. Eliasson MJL, Sampei K, Mandir AS, Hum PD, Traystman RJ, Bao J, Pieper A, Wang Z, Dawson TM, Snyder SH, Dawson VL. Poly (ADP ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nature Med. 1997;3:1089-1095.
25. Endres M, Wang Z, Namura S, Waeber C, Moskowitz MA. Ischemic brain injury is mediated by the activation of poly (ADP ribose) polymerase. J Cereb Blood Flow Metab. 1997;17:1143-1151.
26. Thiemermann C, Bowes J, Myint FP, Vane JR. Inhibition of the activity of poly(ADP-ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle. Proc Natl Acad Sci U S A. 1997;94: 679-683.
27. Lam TT. The effect of 3-aminobenzamide, an inhibitor of PARP on ischemia-reperfusion damage in rat retina. Res Commun Mol Pathol Pharmacol. 1997;95:241-252.
28. Longuemare MC, Swanson RA. Excitatory amino acid release from astrocytes during energy failure by reversal of sodium dependent uptake. J Neurosci Res. 1995;40:379-386.
29. Madl JE, Burgesser K. Adenosine triphosphate depletion reverses sodium-dependent neuronal uptake of glutamate in rat hippocampal slices. J Neurosci. 1993;13:4429-4444.
30. Swanson RA, Chen J, Graham SH. Glucose can fuel glutamate uptake in ischemic brain. J Cereb Blood Flow Metab. 1994;14:1-11.
31. Hagberg H, Lehmann A, Sandberg M, Nystrom B, Jacobsen I, Hamberger A. Ischemic-induced shift of inhibitory and excitatory amino acids from intra to extracellular compartments. J Cereb Blood Flow Metab. 1985;5: 413-419.
32. Kiss Z, Garamszegi N. Overexpression of protein kinase C epsilon enhances the stimulatory effect of ethanol on phospholipase C-mediated hydrolysis of phosphatidylethanolamine. FEBS Lett. 1993;333:229-232.
33. Kiss Z, Tomono M. Compound D609 inhibits phorbol ester stimulated phospholipase D activity and phospholipase C-mediated phosphatidylethanolamine hydrolysis. Biochim Biaphys Acta. 1995;1259:105-108.
34. Huxtable RJ. Taurine in the central nervous system. Prog Neurobiol. 1989;32:471-533.
35. Lehmann A, Hagberg H, Hamberger A. A role for taurine in the maintenance of homeostasis in the central nervous system during hyperexcitation? Neurosci Lett. 1984;52:341-343.
36. Schurr A, Tseng MT, West CA, Rogor BM. Taurine improves recovery of neuronal function following cerebral hypoxia. Life Sci. 1987;40: 2059-2066.
37. Hashimoto A, Oka T, Nishikawa T. Extracellular concentration of endogenous free D-serine in rat brain as revealed by in vivo microdialysis. Neuroscience. 1995;66:635-643.
38. Charriault-Marlange C, Aggoun-Zouaoui D, Represa A, Ben-Ari Y. Apoptotic features of selective neuronal death in ischemia, epilepsy and gp120 toxicity. Trends Neurosci. 1996;19:109-114.
39. Choi DW. Ischemia-induced neuronal apoptosis. Curr Opin Neurobiol. 1996;8:667-672.
40. Chopp M, Li Y. Apoptosis in focal cerebral ischemia. Acta Neurochir (Wien). 1996;suppl 66:21-26.
41. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirer GG, Earnshaw WC. Cleavage of poly(ADP-ribose) polymerase by a protease with properties like ICE. Nature. 1994;371:346-347.
42. Tewari M, Quan LT, O'Rourke K, Salvesen GS, Dixit VM. Yama/ CPP32β. a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 1995;81:801-809.
43. Ellerby HM, Martin SJ, Ellerby LM, Naiem SS, Rabizadeh S, Salvesen GS, Casiano CA, Cashman NR, Green D, Bredesen DE. Establishment of a cell-free system of neuronal apoptosis: comparison of premitochondrial, mitochondria] and postmitochondrial phases. J Neurosci. 1997;17: 6165-6178.
44. Asahi M, Hoshimaru M, Uemera Y, Tokime T, Kojima M, Ohtsuka T, Matsuura N, Aoki T, Shibahara K, Kikuchi H. Expression of interleukin-1B converting enzyme gene family and bcl-2 gene family in the rat brain following permanent occlusion of the middle cerebral artery. J Cereb Blood Flow Metab. 1997;17:11-18.
45. Li Y, Chop M, Powers C, Jiang N. Apoptosis and protein expression after focal cerebral ischemia in rat. Brain Res. 1997;765:301-312.
46. Berger NA. Poly ADP ribose in the cellular response to DNA damage. Radiat Res. 1985;101:4-15.
47. Nagele A. Poly(ADP-ribosyl)ation as a fail-safe transcription-independent suicide mechanism in acutely DNA-damaged cells: a hypothesis. Radiat Environ Biophys. 1995;34:251-254.
48. de Murcia JM, Niedergang C, Trucco C, Ricoul M, Dutrilaux B, Mark M, Olivier F, Masson M, Dierich A, LeMeuer M, Walwinger C, Chambon P, de Murcia G. Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and cells. Proc Natl Acad Sci U S A. 1997; 94:7303-7307.
49. Wang ZQ, Auer B, Stingl L, Berghammer H, Haidacher D, Schweiger M, Wagner EF. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev. 1995;9:509-520.
50. Wang ZQ, Stingl L, Morrison C, Jantsch M, Los M, Osthoff K, Wagner EF. PARP is important for genomic stability but dispensable in apoptosis. Genes Dev. 1997;11:2347-2358.
51. Heller B, Wang Z, Wagner E, Radons J, Burkle A, Fehsei K, Bukhart V, Kolb H. Inactivation of the poly(ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells. J Biol Chem. 1995;270:11176-11180.